BIOX vs EDN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 16, 2026
BIOX
EDN
Investment Advisor Scores
EDN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BIOX | EDN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.9925 | 8.7489 | EDN |
| PEG Ratio | 1.25 | 6.9211 | BIOX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -35.9% | 0.0% | EDN |
| Earnings Growth | 34.4% | 147.5% | EDN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.8/100 | 55.0/100 | EDN |
| Profit Margin | -96.9% | 10.3% | EDN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BIOX
NeutralMixed signals - no dominant trend phase, RSI 56
EDN
MarkupPrice above SMA50, rising 50-day trend (2.1% over 20 days), RSI 55
Fundamentals Snapshot
| Metric | BIOX | EDN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.2 | 10.1 |
| Trailing P/E | — | 5.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.4% | 0.0% |
| Gross Margin | 0.4% | 0.2% |
| Operating Margin | -0.2% | 0.2% |
| EPS | -1.11 | 5.05 |
| Dividend Yield | — | — |